These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1212 related articles for article (PubMed ID: 32146737)

  • 21. Microarray and RASopathy-disorder testing in fetuses with increased nuchal translucency.
    Sinajon P; Chitayat D; Roifman M; Wasim S; Carmona S; Ryan G; Noor A; Kolomietz E; Chong K
    Ultrasound Obstet Gynecol; 2020 Mar; 55(3):383-390. PubMed ID: 31115076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of nuchal translucency thickening in the fetal chromosome abnormality screening].
    Sun LJ; Wang X; Wu QQ; Ruan Y; Yao L
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):819-23. PubMed ID: 24444557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcome in apparently healthy children with increased nuchal translucency in the first trimester screening.
    Äyräs O; Eronen M; Tikkanen M; Rahkola-Soisalo P; Paavonen J; Stefanovic V
    Acta Obstet Gynecol Scand; 2016 May; 95(5):541-6. PubMed ID: 26918672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ultrasound screening and diagnosis of fetal structural abnormalities between 11-14 gestational weeks].
    Markov D; Chernev T; Dimitrova V; Mazneĭkova V; Leroy Y; Jacquemyn Y; Ramaekers P; Van Bulck B; Loquet P
    Akush Ginekol (Sofiia); 2004; 43(3):3-10. PubMed ID: 15341249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of 12-13-week scan for early diagnosis of fetal congenital anomalies in the cell-free DNA era.
    Kenkhuis MJA; Bakker M; Bardi F; Fontanella F; Bakker MK; Fleurke-Rozema JH; Bilardo CM
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):463-469. PubMed ID: 28397377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First-trimester screening for trisomies 18 and 13, triploidy and Turner syndrome by detailed early anomaly scan.
    Wagner P; Sonek J; Hoopmann M; Abele H; Kagan KO
    Ultrasound Obstet Gynecol; 2016 Oct; 48(4):446-451. PubMed ID: 26611869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Birth defects associated with increased nuchal translucency].
    Mendoza-Caamal EC; Grether-González P; Hernández-Gómez M; Guzmán-Huerta M; Aguinaga-Ríos M
    Ginecol Obstet Mex; 2010 Oct; 78(10):533-9. PubMed ID: 21966770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Application of chromosomal microarray analysis in prenatal diagnosis of fetuses with increased nuchal translucency].
    Ni M; Li J; Zhu X; Zhu Y; Gu L; Wu X; Yang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Oct; 36(10):970-974. PubMed ID: 31598938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
    Audibert F; Gagnon A; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10-14 weeks of gestation as part of routine antenatal care in an unselected population.
    Schwärzler P; Carvalho JS; Senat MV; Masroor T; Campbell S; Ville Y
    Br J Obstet Gynaecol; 1999 Oct; 106(10):1029-34. PubMed ID: 10519427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 16-week sonographic findings in fetuses with increased nuchal translucency and a normal array.
    Zhen L; Pan M; Li YT; Cao Q; Xu LL; Li DZ
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):9435-9439. PubMed ID: 35188046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for structural fetal anomalies during the nuchal translucency ultrasound examination.
    Weiner Z; Goldstein I; Bombard A; Applewhite L; Itzkovits-Eldor J
    Am J Obstet Gynecol; 2007 Aug; 197(2):181.e1-5. PubMed ID: 17689643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whole exome sequencing in fetuses with isolated increased nuchal translucency: a systematic review and meta-analysis.
    Di Girolamo R; Rizzo G; Khalil A; Alameddine S; Lisi G; Liberati M; Novelli A; D'Antonio F
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2193285. PubMed ID: 37019452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What would be missed in the first trimester if nuchal translucency measurement is replaced by cell free DNA foetal aneuploidy screening?
    Huang LY; Pan M; Han J; Zhen L; Yang X; Li DZ
    J Obstet Gynaecol; 2018 May; 38(4):498-501. PubMed ID: 29433355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [First trimester ultrasound screening for structural and chromosomal anomalies in multiple pregnancy].
    Markov D; Chernev T; Dimitrova V; Masneĭkova V; Leroy Y; Jacquemyn Y; Ramaekers P; Van Bulck B; Loquet P
    Akush Ginekol (Sofiia); 2004; 43(5):11-8. PubMed ID: 15518278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First Trimester Screening for Fetal Aneuploidies Using Placental Growth Factor: The Great Obstetrical Syndrome (GOS) Study.
    Boutin A; Demers S; Gasse C; Giguère Y; Tétu A; Laforest G; Bujold E
    J Obstet Gynaecol Can; 2018 Aug; 40(8):1044-1049. PubMed ID: 30103877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crown-Rump Length Discordance, Increased Nuchal Translucency, and Detection of Fetal Structural Anomalies in Twin Pregnancies in the First Trimester: 5 Years of Experience in a Tertiary Hospital in China.
    Li X; Xuan Y; Wang J; Wang L; Papageorghiou AT; Wu Q
    J Ultrasound Med; 2022 Apr; 41(4):971-982. PubMed ID: 34289155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pregnancy outcome for fetuses with increased nuchal translucency but normal karyotype.
    Lithner CU; Kublickas M; Ek S
    J Med Screen; 2016 Mar; 23(1):1-6. PubMed ID: 26195563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromosomal microarray analysis in fetuses with aberrant right subclavian artery.
    Maya I; Kahana S; Yeshaya J; Tenne T; Yacobson S; Agmon-Fishman I; Cohen-Vig L; Levi A; Reinstein E; Basel-Vanagaite L; Sharony R
    Ultrasound Obstet Gynecol; 2017 Mar; 49(3):337-341. PubMed ID: 27063194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for aneuploidies by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-13+6 gestational weeks.
    Karadzov-Orlić N; Egić A; Filimonović D; Marinković M; Damnjanović-Pazin B; Milovanović Z; Joksić I; Branković S; Lukić R; Mandić V; Cerović N; Mojović D; Plamenac S; Stanković M; Maglić D; Mikovć Z
    Srp Arh Celok Lek; 2012; 140(9-10):606-11. PubMed ID: 23289277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 61.